Detalles de la búsqueda
1.
Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility.
Pharmacoepidemiol Drug Saf
; 29(1): 18-29, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950565
2.
Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs.
Pharmacoepidemiol Drug Saf
; 27(10): 1147-1150, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29250905
3.
Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).
Eur J Clin Pharmacol
; 73(1): 115-123, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27787616
4.
Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).
Pharmacoepidemiol Drug Saf
; 24(9): 999-1003, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26213344
5.
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies.
Pharmacoepidemiol Drug Saf
; 21(11): 1202-15, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22763953
6.
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.
BMJ Open Diabetes Res Care
; 5(1): e000400, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28878934
7.
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs.
BMC Pharmacol Toxicol
; 16: 8, 2015 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25889498
8.
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
Drug Saf
; 36(2): 119-34, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23329543
Resultados
1 -
8
de 8
1
Próxima >
>>